Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis

Abstract

The CCB nilvadipine exercises an inhibitory effect on the pathogenesis of ocular inflammation through the suppression of inflammation-related molecules.

Effect of Nisoldipine and Olmesartan on Endothelium‐Dependent Vasodilation in Essential Hypertensive Patients

“…Previous studies have reported that calcium channel blockers [31,32] have antiinflammatory properties. Calcium channel blockers decrease CRP by reducing the production of interluekin-1 and transforming growth factor, avoiding stimulating the production of CRP in hepatic cells.…”